Karen Cross, MIMOSA Diagnostics Inc. - NIR Imaging Device for Early Tissue Compromise | LSI USA '25

MIMOSA Diagnostics Inc. revolutionizes healthcare with its non-invasive technology designed to provide real-time, actionable data for chronic wound management and skin health assessment. Their mission is to enhance patient care and outcomes through innovative solutions that empower both healthcare professionals and patients.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Karen Cross
CEO, MIMOSA Diagnostics Inc.